The Cancer Care Crisis
-
Over 4 million cancer cases annually in the EU by 2025.
-
Radiotherapy is essential for over 50% of all patients, yet access is inconsistent.
-
Only 17% of EU countries effectively treat >80% of cancer patients.
-
Positioning alone takes 25–45 minutes per session, reducing capacity and delaying care.
Cancer Treatment Is in Crisis
What is Protonshot?
AiDDA's ProtonShot: Precision in Under 5 Minutes
-
Uses daily CBCT, AI algorithms, and Monte Carlo dose calculations to align patients accurately.
-
Fits into existing hospital infrastructure without workflow disruption.
Why It Matters
The AIDDA Advantage:
Data-Driven,
Patient-Centered
Key Benefits
-
~ 5 Minutes Setup time – 60% faster.
-
Up to + 80% Throughput – More patients treated daily.
-
Dose-Guided Accuracy – Physician prescribed dosimetric insights, online
-
Reduced Costs – Less dependency on highly skilled therapists.
-
Greater Access to care, without additional infrastructure.
Meet the AiDDA Founders
Experienced Minds Behind AIDDA
Daniele Farina
Founder & CEO
Executive MBA in AI, data & analytics.
Stefan Both
Founder & CSO
Medical physics professor, proton therapy chair.
Gabriel Guterres Marmitt
Founder & CTO
Expert in computational physics and MedTech systems.